IPP Bureau
Reforms in Ayush to boost growth: Sarbananda Sonowal
By IPP Bureau - November 24, 2022
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
Centre deploys three teams to manage high measles cases among children
By IPP Bureau - November 24, 2022
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
Dr. Bharti Pawar to participate in Global Conference on Antimicrobial Resistance
By IPP Bureau - November 24, 2022
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
SRL Diagnostics hosts ‘International Gynecologic & Breast Cancer Symposium 2022’
By IPP Bureau - November 23, 2022
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
Ministry of Ayush announces setting up of Academic Chair at Western Sydney University
By IPP Bureau - November 23, 2022
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
USFDA grants priority review of BLA for dengue vaccine TAK-003
By IPP Bureau - November 23, 2022
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
Ajooni Biotech awarded ZED certification by Ministry of MSME
By IPP Bureau - November 22, 2022
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets
By IPP Bureau - November 22, 2022
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Lupin signs MoU with Govt. of Rajasthan to strengthen healthcare system
By IPP Bureau - November 22, 2022
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr
By IPP Bureau - November 22, 2022
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Merck to acquire Imago BioSciences for $1.35 bn
By IPP Bureau - November 22, 2022
Acquisition expands Merck’s growing hematology portfolio
Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar
By IPP Bureau - November 21, 2022
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
By IPP Bureau - November 21, 2022
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures
By IPP Bureau - November 21, 2022
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
USFDA completes pre-approval inspection of BHL's Vadodara facility
By IPP Bureau - November 21, 2022
The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited
